Pete Martin
Papers
2
Total Citations
249
H-Index
2
About
Pete Martin’s research sits at the critical intersection of prenatal diagnostics and transfusion medicine, with a primary focus on preventing hemolytic disease of the fetus and newborn. His most impactful work, a 2008 prospective feasibility study cited over 230 times, demonstrated the clinical utility of high-throughput, automated robotic RHD genotyping from fetal DNA circulating in maternal plasma. By accurately predicting fetal RhD phenotype in RhD-negative pregnant women, Martin’s method enabled a targeted, evidence-based approach to anti-RhD immunoglobulin administration. This innovation directly addressed the problem of unnecessary prophylaxis, showing that mass antenatal screening could substantially reduce the use of this blood product while still protecting at-risk pregnancies. Martin’s contribution is notable for translating a complex molecular technique—non-invasive prenatal testing—into a practical, scalable clinical workflow. His work has had a lasting impact on obstetric guidelines, helping to shift practice from universal prophylaxis to a more personalized, resource-efficient model. For students and researchers, Martin exemplifies how rigorous feasibility studies can bridge laboratory science and direct patient care, improving safety and efficiency in routine antenatal management.
Research Focus
Key Achievements
Top Papers
- 1
- 2